Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: Lessons learned from animal models and human genetics

Luca Pastorelli, Carlo De Salvo, Joseph R. Mercado, Maurizio Vecchi, Theresa T. Pizarro

Research output: Contribution to journalReview article

Abstract

The gut mucosa is constantly challenged by a bombardment of foreign antigens and environmental microorganisms. As such, the precise regulation of the intestinal barrier allows the maintenance of mucosal immune homeostasis and prevents the onset of uncontrolled inflammation. In support of this concept, emerging evidence points to defects in components of the epithelial barrier as etiologic factors in the pathogenesis of inflammatory bowel diseases (IBDs). In fact, the integrity of the intestinal barrier relies on different elements, including robust innate immune responses, epithelial paracellular permeability, epithelial cell integrity, as well as the production of mucus. The purpose of this review is to systematically evaluate how alterations in the aforementioned epithelial components can lead to the disruption of intestinal immune homeostasis, and subsequent inflammation. In this regard, the wealth of data from mouse models of intestinal inflammation and human genetics are pivotal in understanding pathogenic pathways, for example, that are initiated from the specific loss of function of a single protein leading to the onset of intestinal disease. On the other hand, several recently proposed therapeutic approaches to treat human IBD are targeted at enhancing different elements of gut barrier function, further supporting a primary role of the epithelium in the pathogenesis of chronic intestinal inflammation and emphasizing the importance of maintaining a healthy and effective intestinal barrier.

Original languageEnglish (US)
Article numberArticle 280
JournalFrontiers in immunology
Volume4
Issue numberSEP
DOIs
StatePublished - Oct 28 2013
Externally publishedYes

Fingerprint

Medical Genetics
Animal Models
Inflammation
Inflammatory Bowel Diseases
Homeostasis
Intestinal Diseases
Mucus
Innate Immunity
Permeability
Mucous Membrane
Epithelium
Epithelial Cells
Maintenance
Antigens
Proteins
Therapeutics

Keywords

  • Animal models of intestinal inflammation
  • Crohn's disease
  • Gut immune homeostasis
  • Inflammatory bowel disease genetics
  • Innate immunity
  • Intestinal barrier function
  • Intestinal epithelial cells
  • Ulcerative colitis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation : Lessons learned from animal models and human genetics. / Pastorelli, Luca; Salvo, Carlo De; Mercado, Joseph R.; Vecchi, Maurizio; Pizarro, Theresa T.

In: Frontiers in immunology, Vol. 4, No. SEP, Article 280, 28.10.2013.

Research output: Contribution to journalReview article

@article{8e141c4cb0904b16bda04a892bd2828e,
title = "Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: Lessons learned from animal models and human genetics",
abstract = "The gut mucosa is constantly challenged by a bombardment of foreign antigens and environmental microorganisms. As such, the precise regulation of the intestinal barrier allows the maintenance of mucosal immune homeostasis and prevents the onset of uncontrolled inflammation. In support of this concept, emerging evidence points to defects in components of the epithelial barrier as etiologic factors in the pathogenesis of inflammatory bowel diseases (IBDs). In fact, the integrity of the intestinal barrier relies on different elements, including robust innate immune responses, epithelial paracellular permeability, epithelial cell integrity, as well as the production of mucus. The purpose of this review is to systematically evaluate how alterations in the aforementioned epithelial components can lead to the disruption of intestinal immune homeostasis, and subsequent inflammation. In this regard, the wealth of data from mouse models of intestinal inflammation and human genetics are pivotal in understanding pathogenic pathways, for example, that are initiated from the specific loss of function of a single protein leading to the onset of intestinal disease. On the other hand, several recently proposed therapeutic approaches to treat human IBD are targeted at enhancing different elements of gut barrier function, further supporting a primary role of the epithelium in the pathogenesis of chronic intestinal inflammation and emphasizing the importance of maintaining a healthy and effective intestinal barrier.",
keywords = "Animal models of intestinal inflammation, Crohn's disease, Gut immune homeostasis, Inflammatory bowel disease genetics, Innate immunity, Intestinal barrier function, Intestinal epithelial cells, Ulcerative colitis",
author = "Luca Pastorelli and Salvo, {Carlo De} and Mercado, {Joseph R.} and Maurizio Vecchi and Pizarro, {Theresa T.}",
year = "2013",
month = "10",
day = "28",
doi = "10.3389/fimmu.2013.00280",
language = "English (US)",
volume = "4",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
number = "SEP",

}

TY - JOUR

T1 - Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation

T2 - Lessons learned from animal models and human genetics

AU - Pastorelli, Luca

AU - Salvo, Carlo De

AU - Mercado, Joseph R.

AU - Vecchi, Maurizio

AU - Pizarro, Theresa T.

PY - 2013/10/28

Y1 - 2013/10/28

N2 - The gut mucosa is constantly challenged by a bombardment of foreign antigens and environmental microorganisms. As such, the precise regulation of the intestinal barrier allows the maintenance of mucosal immune homeostasis and prevents the onset of uncontrolled inflammation. In support of this concept, emerging evidence points to defects in components of the epithelial barrier as etiologic factors in the pathogenesis of inflammatory bowel diseases (IBDs). In fact, the integrity of the intestinal barrier relies on different elements, including robust innate immune responses, epithelial paracellular permeability, epithelial cell integrity, as well as the production of mucus. The purpose of this review is to systematically evaluate how alterations in the aforementioned epithelial components can lead to the disruption of intestinal immune homeostasis, and subsequent inflammation. In this regard, the wealth of data from mouse models of intestinal inflammation and human genetics are pivotal in understanding pathogenic pathways, for example, that are initiated from the specific loss of function of a single protein leading to the onset of intestinal disease. On the other hand, several recently proposed therapeutic approaches to treat human IBD are targeted at enhancing different elements of gut barrier function, further supporting a primary role of the epithelium in the pathogenesis of chronic intestinal inflammation and emphasizing the importance of maintaining a healthy and effective intestinal barrier.

AB - The gut mucosa is constantly challenged by a bombardment of foreign antigens and environmental microorganisms. As such, the precise regulation of the intestinal barrier allows the maintenance of mucosal immune homeostasis and prevents the onset of uncontrolled inflammation. In support of this concept, emerging evidence points to defects in components of the epithelial barrier as etiologic factors in the pathogenesis of inflammatory bowel diseases (IBDs). In fact, the integrity of the intestinal barrier relies on different elements, including robust innate immune responses, epithelial paracellular permeability, epithelial cell integrity, as well as the production of mucus. The purpose of this review is to systematically evaluate how alterations in the aforementioned epithelial components can lead to the disruption of intestinal immune homeostasis, and subsequent inflammation. In this regard, the wealth of data from mouse models of intestinal inflammation and human genetics are pivotal in understanding pathogenic pathways, for example, that are initiated from the specific loss of function of a single protein leading to the onset of intestinal disease. On the other hand, several recently proposed therapeutic approaches to treat human IBD are targeted at enhancing different elements of gut barrier function, further supporting a primary role of the epithelium in the pathogenesis of chronic intestinal inflammation and emphasizing the importance of maintaining a healthy and effective intestinal barrier.

KW - Animal models of intestinal inflammation

KW - Crohn's disease

KW - Gut immune homeostasis

KW - Inflammatory bowel disease genetics

KW - Innate immunity

KW - Intestinal barrier function

KW - Intestinal epithelial cells

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=84886014303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886014303&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2013.00280

DO - 10.3389/fimmu.2013.00280

M3 - Review article

AN - SCOPUS:84886014303

VL - 4

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - SEP

M1 - Article 280

ER -